BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

468 related articles for article (PubMed ID: 9744545)

  • 21. 22-Oxa-1,25(OH)2vitamin D3, a synthetic analogue of vitamin D3, has no promoting activity in a rat liver medium-term bioassay.
    Otoshi T; Iwata H; Takada N; Nishisawa Y; Morii H; Fukushima S
    Cancer Lett; 1994 Aug; 83(1-2):69-74. PubMed ID: 8062235
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dose-dependent effects of 2-acetylaminofluorene on hepatic foci development and cell proliferation in rats.
    Tiwawech D; Hasegawa R; Kurata Y; Tatematsu M; Shibata MA; Thamavit W; Ito N
    Carcinogenesis; 1991 Jun; 12(6):985-90. PubMed ID: 2044205
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Possible prevention by abieslactone of development of diethylnitrosamine-initiated GST-P positive foci in the rat liver.
    Iwai S; Wei M; Morimura K; Wanibuchi H; Tanaka R; Matsunaga S; Yoshitake A; Seki S; Fukushima S
    Teratog Carcinog Mutagen; 2001; 21(3):223-9. PubMed ID: 11301417
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The relationship between decrease in Cx32 and induction of P450 isozymes in the early phase of clofibrate hepatocarcinogenesis in the rat.
    Shoda T; Mitsumori K; Onodera H; Toyoda K; Uneyama C; Imazawa T; Hirose M
    Arch Toxicol; 1999 Sep; 73(7):373-80. PubMed ID: 10550479
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Enhancement of hepatocarcinogenesis by kojic acid in rat two-stage models after initiation with N-bis(2-hydroxypropyl)nitrosamine or N-diethylnitrosamine.
    Takizawa T; Imai T; Onose J; Ueda M; Tamura T; Mitsumori K; Izumi K; Hirose M
    Toxicol Sci; 2004 Sep; 81(1):43-9. PubMed ID: 15201437
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Liver medium-term bioassay in rats for screening of carcinogens and modifying factors in hepatocarcinogenesis.
    Hasegawa R; Ito N
    Food Chem Toxicol; 1992 Nov; 30(11):979-92. PubMed ID: 1473791
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular profiling of genes up-regulated during promotion by phenobarbital treatment in a medium-term rat liver bioassay.
    Shibutani M; Takahashi N; Kobayashi T; Uneyama C; Masutomi N; Nishikawa A; Hirose M
    Carcinogenesis; 2002 Jun; 23(6):1047-55. PubMed ID: 12082028
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Promotion potential of tamoxifen on hepatocarcinogenesis in female SD or F344 rats initiated with diethylnitrosamine.
    Kim DJ; Han BS; Ahn B; Lee KK; Kang JS; Tsuda H
    Cancer Lett; 1996 Jun; 104(1):13-9. PubMed ID: 8640739
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Low dose DDT inhibition of hepatocarcinogenesis initiated by diethylnitrosamine in male rats: possible mechanisms.
    Kushida M; Sukata T; Uwagawa S; Ozaki K; Kinoshita A; Wanibuchi H; Morimura K; Okuno Y; Fukushima S
    Toxicol Appl Pharmacol; 2005 Nov; 208(3):285-94. PubMed ID: 15885732
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synergistic effects of low-dose hepatocarcinogens in induction of glutathione S-transferase P-positive foci in the rat liver.
    Hasegawa R; Mutai M; Imaida K; Tsuda H; Yamaguchi S; Ito N
    Jpn J Cancer Res; 1989 Oct; 80(10):945-51. PubMed ID: 2482284
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibitory effects of low doses of melatonin on induction of preneoplastic liver lesions in a medium-term liver bioassay in F344 rats: relation to the influence of electromagnetic near field exposure.
    Imaida K; Hagiwara A; Yoshino H; Tamano S; Sano M; Futakuchi M; Ogawa K; Asamoto M; Shirai T
    Cancer Lett; 2000 Jul; 155(1):105-14. PubMed ID: 10814886
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Alterations in populations of GST-p-immunoreactive single hepatocytes and hepatocellular foci after a single injection of N-nitrosodiethylamine with or without phenobarbital promotion in male F344/NCr rats.
    Jang JJ; Henneman JR; Kurata Y; Uno H; Ward JM
    Cancer Lett; 1993 Jul; 71(1-3):89-95. PubMed ID: 8364903
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Non-carcinogenicity, but dose-related increase in preneoplastic hepatocellular lesions, in a two-year feeding study of phenobarbital sodium in male F344 rats.
    Hagiwara A; Miyata E; Tamano S; Sano M; Masuda C; Funae Y; Ito N; Fukushima S; Shirai T
    Food Chem Toxicol; 1999 Aug; 37(8):869-79. PubMed ID: 10506011
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Dose-response relationship of promotion by phenobarbital in rat two-stage hepatocarcinogenesis].
    Onodera H; Matsushima Y; Uneyama C; Shibutani M; Mitsumori K; Maekawa A; Hayashi Y
    Eisei Shikenjo Hokoku; 1991; (109):55-60. PubMed ID: 1364405
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rapid development of hepatic tumors in transforming growth factor alpha transgenic mice associated with increased cell proliferation in precancerous hepatocellular lesions initiated by N-nitrosodiethylamine and promoted by phenobarbital.
    Tamano S; Merlino GT; Ward JM
    Carcinogenesis; 1994 Sep; 15(9):1791-8. PubMed ID: 7923571
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Suppressive effect of enzymatically modified isoquercitrin on phenobarbital-induced liver tumor promotion in rats.
    Morita R; Shimamoto K; Ishii Y; Kuwata K; Ogawa B; Imaoka M; Hayashi SM; Suzuki K; Shibutani M; Mitsumori K
    Arch Toxicol; 2011 Nov; 85(11):1475-84. PubMed ID: 21445586
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Promoting effects of monomethylarsonic acid, dimethylarsinic acid and trimethylarsine oxide on induction of rat liver preneoplastic glutathione S-transferase placental form positive foci: a possible reactive oxygen species mechanism.
    Nishikawa T; Wanibuchi H; Ogawa M; Kinoshita A; Morimura K; Hiroi T; Funae Y; Kishida H; Nakae D; Fukushima S
    Int J Cancer; 2002 Jul; 100(2):136-9. PubMed ID: 12115560
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chloroform inhibits the development of diethylnitrosamine-initiated, phenobarbital-promoted gamma-glutamyltranspeptidase and placental form glutathione S-transferase-positive foci in rat liver.
    Reddy TV; Daniel FB; Lin EL; Stober JA; Olson GR
    Carcinogenesis; 1992 Aug; 13(8):1325-30. PubMed ID: 1354081
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Promoting potential of a Jamaica quassia extract in a rat medium-term hepatocarcinogenesis bioassay.
    Woo GH; Shibutani M; Inoue K; Fujimoto H; Takahashi M; Lee KY; Hirose M
    Food Chem Toxicol; 2007 Jul; 45(7):1160-4. PubMed ID: 17306917
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dose-dependent induction of GST-P+ staining foci by the rat hepatocarcinogen methapyrilene in the medium-term bioassay.
    Horn DM; Jordan WH; Holloway DC; Smith WC; Richardson FC
    Fundam Appl Toxicol; 1996 Feb; 29(2):194-7. PubMed ID: 8742315
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.